Medical Costs and Healthcare Utilization among Cancer Decedents in the Last Year of Life in 2009

Cancer Research and Treatment : Official Journal of Korean Cancer Association
Inuk HwangJong-Hyock Park

Abstract

The purpose of this study was to evaluate the cancer care cost during the last year of life of patients in Korea. We studied the breakdown of spending on the components of cancer care. Cancer decedents in 2009 were identified from the Korean Central Cancer Registry and linked with the Korean National Health Insurance Claims Database. The final number of patients included in the study was 70,558. In 2009, the average cancer care cost during the last year of life was US $15,720. Patients under age 20 spent US $53,890 while those 70 or over spent US $11,801. Those with leukemia incurred the highest costs (US $43,219) while bladder cancer patients spent the least (US $13,155). General costs, drugs other than analgesics, and test fees were relatively high (29.7%, 23.8%, and 20.7% of total medical costs, respectively). Analgesic drugs, rehabilitation, and psychotherapy were still relatively low (4.3%, 0.7%, and 0.1%, respectively). Among the results of multiple regression analysis, few were notable. Age was found to be negatively related to cancer care costs while income level was positively associated. Those classified under distant Surveillance, Epidemiology, and End Results stages of cancer and higher comorbidity level also incurr...Continue Reading

References

Jun 1, 1994·American Journal of Physical Medicine & Rehabilitation·H Yoshioka
Feb 3, 2000·Journal of the National Cancer Institute·W F AthasC R Key
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F I Fawzy
Mar 29, 2001·Annual Review of Public Health·M L BrownC Snyder
Jul 21, 2001·Health Affairs·C HoganJ Lynn
Aug 21, 2002·Medical Care·Martin L BrownRuth Etzioni
Feb 22, 2007·Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi·Soo-Young ChooOk Ryun Moon
Oct 30, 2007·Nature Clinical Practice. Oncology·K Robin YabroffMartin L Brown
Apr 16, 2008·Japanese Journal of Clinical Oncology·Bhumsuk KeamDae Seog Heo
Dec 2, 2009·Journal of Urban Health : Bulletin of the New York Academy of Medicine·David Sharp
Apr 29, 2010·JAMA : the Journal of the American Medical Association·Michaela A DinanKevin A Schulman
Jan 14, 2011·Journal of the National Cancer Institute·Angela B MariottoMartin L Brown
Feb 16, 2011·International Journal of Health Services : Planning, Administration, Evaluation·Tae Ho YoonHyeung-Keun Park
Oct 8, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·K Robin YabroffAngela Mariotto
Dec 22, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Yang Yang, Johannes Czernin
Apr 14, 2012·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Kyu-Won JungJin-Soo Lee
Apr 20, 2013·Journal of Oncology Practice·Benjamin ChastekApril H Teitelbaum

❮ Previous
Next ❯

Citations

Sep 24, 2016·American Journal of Physical Medicine & Rehabilitation·Stacy McCartyAlex W K Wong
Jul 15, 2017·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Shin Hye YooDae Seog Heo
Jan 25, 2018·Journal of Palliative Care·Su Hyun KimMi-Kyung Song
Jun 9, 2021·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Audrey Tanguy-MelacChristelle Gastaldi-Ménager

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.